Pfizer to buy Allergan in US$160b deal to create No 1 drugmaker
Acquisition will be biggest this year; Pfizer chief will head combined company
Add BT as a preferred source
New York
PFIZER Inc, the maker of Viagra and Lipitor, has struck a deal to buy Botox-maker Allergan plc in a transaction valued at about US$160 billion, creating the world's biggest drugmaker. New York-based Pfizer and Allergan, headquartered in Ireland, said on Monday that Pfizer would offer 11.3 of its own shares for each Allergan share.
Pfizer stockholders will receive one share of the combined company for each of their Pfizer shares. The offer values Allergan's shares at US$363.63 each, compared with the stock's close of US$312.46 on Friday.
TRENDING NOW
On the board but frozen out: The Taib family feud tearing Sarawak construction giant apart
That ‘cheap’ Malaysia condo could cost Singapore buyers far more than they think
Malaysian fugitive Jho Low seeks Trump pardon in 1MDB case
Asean+3 has made strong progress on cross-border payment connectivity, but more work lies ahead
